Aidoc reports customer milestone

Israeli artificial intelligence software developer Aidoc said that the Foundation...Read more on AuntMinnie.comRelated Reading: Aidoc releases full AI software package for stroke care Aidoc nabs NY contract for AI software FDA clears Aidoc's AI for cervical spine fractures Aidoc scores FDA clearance for pulmonary embolism AI Aidoc raises $27M in funding round
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news

Related Links:

Abstract BACKGROUND: There remains uncertainty in the optimal prognostication and management of patients with intermediate-risk PE. Transthoracic echocardiography can identify right ventricular (RV) dysfunction to recognise intermediate-high risk patients. RESEARCH QUESTION: The aim of this study was to test whether echocardiography-derived stroke volume index (SVI) is associated with death or cardiopulmonary decompensation in intermediate-risk patients with pulmonary embolism (PE). STUDY DESIGN AND METHODS: We retrospectively evaluated echocardiographic-derived variables including SVI in normotensive pa...
Source: Chest - Category: Respiratory Medicine Authors: Tags: Chest Source Type: research
RARITAN, NJ, March 28, 2020 – The Janssen Pharmaceutical Companies of Johnson &Johnson today announced the VOYAGER PAD study met its primary efficacy and principal safety endpoints, demonstrating the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily) plus aspirin (100 mg once daily) was superior to aspirin alone in reducing the risk of major adverse limb and cardiovascular (CV) events by 15 percent in patients with symptomatic peripheral artery disease (PAD) after lower-extremity revascularization, with similar rates of TIMI[1] major bleeding. VOYAGER PAD is the only study to show a significant benefit...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news
AbstractHigh-risk PE can be complicated by the presence of a patent foramen ovale (PFO), which can lead to paradoxical systemic embolization, including cerebral embolism ultimately leading to acute ischemic stroke (AIS). Acute management is challenging given the competing benefits and risks of systemic thrombolysis. Herein, we aim to provide a review of clinical presentations, diagnostic findings, and treatment and outcome from the available literature, with the hopes of providing insight into treatment options. We followed the guidelines outlined by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (P...
Source: Emergency Radiology - Category: Emergency Medicine Source Type: research
PS Abstract BACKGROUND: Isolated PE is associated with a higher burden of atherosclerotic disease than other manifestations of venous thromboembolism (VTE). RESEARCH QUESTION: We hypothesized that the presence of isolated PE may signal a chronically elevated risk of arterial thrombotic disease. STUDY DESIGN AND METHODS: Data from the VTEval Study, a prospective cohort study enrolling individuals with clinical suspicion and imaging-based diagnosis or exclusion of VTE, were analyzed. Patients with PE received whole-leg ultrasonography to assess presence of deep vein thrombosis (DVT). Regularized logistic ...
Source: Chest - Category: Respiratory Medicine Authors: Tags: Chest Source Type: research
Extracorporeal membrane oxygenation (ECMO) has become a common treatment strategy with increasing clinical experience and technological advances in recent years.1,2 According to the Extracorporeal Life Support Organization (ELSO) data, 45,299 adult patients with cardiac, pulmonary and extracorporeal cardiopulmonary resuscitation (ECPR) were treated with ECMO in 2019, and survival and discharge rates after ECMO gradually increased.3 ECMO can last for days or weeks. However, such complications as bleeding, stroke, delirium, acute renal failure, pulmonary embolism, displacement of cannulas, vascular perforation and lower extr...
Source: Heart and Lung - Category: Intensive Care Authors: Source Type: research
RARITAN, N.J., March 20, 2020 – The Janssen Pharmaceutical Companies of Johnson &Johnson announced today that it will unveil late-breaking data from its leading cardiovascular and metabolism portfolio during the virtual American College of Cardiology’s 69th Annual Scientific Session together with the World Congress of Cardiology (ACC.20/WCC) on March 28-30, 2020. Notably, four late-breaking abstracts for XARELTO® (rivaroxaban) will be presented, including data from the Phase 3 VOYAGER PAD study in patients with symptomatic peripheral artery disease (PAD) after lower-extremity revascularization.Click to ...
Source: Johnson and Johnson - Category: Pharmaceuticals Source Type: news
Abstract BACKGROUND: Guidelines outlining the role of surgical embolectomy for acute pulmonary embolism remain consensus based, however recent outcomes have improved compared to traditional experiences. The purpose of this study was to examine contemporary outcomes of patients treated for acute pulmonary embolism on a nationwide scale. METHODS: Patients undergoing systemic thrombolysis, catheter-directed therapy, and surgical embolectomy for acute pulmonary embolism from 2010-2014 in the National Inpatient Sample were included. RESULTS: A total 58,974 patients with acute pulmonary embolism were included....
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: Ann Thorac Surg Source Type: research
The objective of the present study was to determine whether patients with an active cannabis use disorder have an elevated risk of postoperative complications.Methods The authors conducted a retrospective population-based cohort study of patients undergoing elective surgery in the United States using the Nationwide Inpatient Sample from 2006 to 2015. A sample of 4,186,622 inpatients 18 to 65 yr of age presenting for 1 of 11 elective surgeries including total knee replacement, total hip replacement, coronary artery bypass graft, caesarian section, cholecystectomy, colectomy, hysterectomy, breast surgery, hernia repair, lami...
Source: Anesthesiology - Category: Anesthesiology Source Type: research
There are over 36 million medical hospitalizations each year in the United States, with the majority being for acute medical illness.1 Cancer, chronic obstructive pulmonary disease, congestive heart failure, stroke and myocardial infarction are some of the most common indications for hospitalization and are additionally risk factors for venous thromboembolism.2 With over 900,000 patients suffering from venous thromboembolism each year, excess thrombosis causes a large medical and financial burden to patients and the health care system.
Source: The American Journal of Medicine - Category: General Medicine Authors: Tags: Clinical Research Study Source Type: research
ConclusionsIn patients undergoing AF ablation, we identified the use of NOAC and intraprocedural cardioversion as independent risk factors for the occurrence of periprocedural cerebral embolic lesions.
Source: Journal of Interventional Cardiac Electrophysiology - Category: Cardiology Source Type: research
More News: Contracts | Funding | Israel Health | Pulmonary Thromboembolism | Radiology | Stroke